BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 34018031)

  • 1. Effect of high-intensity interval training on patient-reported outcomes and physical function in women with breast cancer receiving anthracycline-based chemotherapy.
    Lee K; Norris MK; Wang E; Dieli-Conwright CM
    Support Care Cancer; 2021 Nov; 29(11):6863-6870. PubMed ID: 34018031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study.
    Lee K; Kang I; Mack WJ; Mortimer J; Sattler F; Salem G; Lu J; Dieli-Conwright CM
    Breast Cancer Res Treat; 2019 Sep; 177(2):477-485. PubMed ID: 31236810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial.
    Lee K; Kang I; Mack WJ; Mortimer J; Sattler F; Salem G; Dieli-Conwright CM
    BMC Cancer; 2019 Jul; 19(1):653. PubMed ID: 31269914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of High Intensity Interval Training on Matrix Metalloproteinases in Women with Breast Cancer Receiving Anthracycline-Based Chemotherapy.
    Lee K; Kang I; Mack WJ; Mortimer J; Sattler F; Salem G; Dieli-Conwright CM
    Sci Rep; 2020 Apr; 10(1):5839. PubMed ID: 32246106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study to assess the feasibility of a remotely monitored high-intensity interval training program prior to allogeneic hematopoietic stem cell transplantation.
    Artese AL; Winthrop HM; Bohannon L; Lew MV; Johnson E; MacDonald G; Ren Y; Pastva AM; Hall KS; Wischmeyer PE; Macleod D; Molinger J; Barth S; Jung SH; Cohen HJ; Bartlett DB; Sung AD
    PLoS One; 2023; 18(11):e0293171. PubMed ID: 38032994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation Mediates Exercise Effects on Fatigue in Patients with Breast Cancer.
    Hiensch AE; Mijwel S; Bargiela D; Wengström Y; May AM; Rundqvist H
    Med Sci Sports Exerc; 2021 Mar; 53(3):496-504. PubMed ID: 32910094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress is not so bad-cortisol level and psychological functioning after 8-week HIIT program during pregnancy: a randomized controlled trial.
    Wilczyńska D; Walczak-Kozłowska T; Santos-Rocha R; Laskowski R; Szumilewicz A
    Front Public Health; 2023; 11():1307998. PubMed ID: 38259751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Aerobic Training on Cardiovascular Function, Fitness, and Patient Reported Outcomes During Anthracycline Chemotherapy: A Case Series in Women With Breast Cancer.
    Murray J; Bennett H; Selva-Nayagam S; Joshi R; Bezak E; Perry R
    Integr Cancer Ther; 2023; 22():15347354231210874. PubMed ID: 37961905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chemotherapy treatment on muscle strength indicators, functional capacity and biopsychosocial aspects of women with breast cancer.
    Alves RR; Marques VA; da Silva WA; Freitas-Junior R; da Cruz AM; Del Vecchio FB; Rosa VDL; Vieira CA
    Am J Cancer Res; 2024; 14(2):762-773. PubMed ID: 38455416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy de-escalation using an
    Pérez-García JM; Gebhart G; Ruiz Borrego M; Stradella A; Bermejo B; Schmid P; Marmé F; Escrivá-de-Romani S; Calvo L; Ribelles N; Martinez N; Albacar C; Prat A; Dalenc F; Kerrou K; Colleoni M; Afonso N; Di Cosimo S; Sampayo-Cordero M; Malfettone A; Cortés J; Llombart-Cussac A;
    Lancet Oncol; 2021 Jun; 22(6):858-871. PubMed ID: 34019819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non-Small Cell Lung Cancer.
    Kehl KL; Greenwald S; Chamoun NG; Manberg PJ; Schrag D
    JAMA Netw Open; 2021 May; 4(5):e2111113. PubMed ID: 34019086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and functional effects of TERT variants in myelodysplastic syndrome.
    Reilly CR; Myllymäki M; Redd R; Padmanaban S; Karunakaran D; Tesmer V; Tsai FD; Gibson CJ; Rana HQ; Zhong L; Saber W; Spellman SR; Hu ZH; Orr EH; Chen MM; De Vivo I; DeAngelo DJ; Cutler C; Antin JH; Neuberg D; Garber JE; Nandakumar J; Agarwal S; Lindsley RC
    Blood; 2021 Sep; 138(10):898-911. PubMed ID: 34019641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ.
    Gupta A; Jhawar SR; Sayan M; Yehia ZA; Haffty BG; Yu JB; Wang SY
    J Clin Oncol; 2021 Jul; 39(21):2386-2396. PubMed ID: 34019456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study.
    Kotani D; Yoshino T; Kotaka M; Kawazoe A; Masuishi T; Taniguchi H; Yamazaki K; Yamanaka T; Oki E; Muro K; Komatsu Y; Bando H; Satake H; Kato T; Tsuji A
    Invest New Drugs; 2021 Dec; 39(6):1649-1655. PubMed ID: 34019214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participants.
    Ogasawara K; Kam J; Thomas M; Liu L; Liu M; Xue Y; Surapaneni S; Carayannopoulos LN; Zhou S; Palmisano M; Krishna G
    Cancer Chemother Pharmacol; 2021 Sep; 88(3):369-377. PubMed ID: 34019108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote.
    Sheng JY; Santa-Maria CA; Blackford AL; Lim D; Carpenter A; Smith KL; Cohen GI; Coughlin J; Appel LJ; Stearns V; Snyder C
    J Cancer Surviv; 2022 Jun; 16(3):542-551. PubMed ID: 34018096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual care.
    Kirkham AA; King K; Joy AA; Pelletier AB; Mackey JR; Young K; Zhu X; Meza-Junco J; Basi SK; Hiller JP; Brkin T; Michalowski B; Pituskin E; Paterson DI; Courneya KS; Thompson RB; Prado CM
    BMC Cancer; 2021 Oct; 21(1):1093. PubMed ID: 34629067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer and exeRcise trAining during intraVesical thErapy-the BRAVE trial: a study protocol for a prospective, single-centre, phase II randomised controlled trial.
    Arthuso FZ; Fairey AS; Boulé NG; Courneya KS
    BMJ Open; 2021 Sep; 11(9):e055782. PubMed ID: 34561265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training and detraining effects on body composition, muscle strength and lipid, inflammatory and oxidative markers in breast cancer survivors under tamoxifen treatment.
    de Jesus Leite MAF; Mariano IM; Dechichi JGC; Giolo JS; Gonçalves ÁC; Puga GM
    Life Sci; 2021 Nov; 284():119924. PubMed ID: 34480935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of exercise in breast cancer patients: implications of the trials within cohorts (TwiCs) design in the UMBRELLA Fit trial.
    Gal R; Monninkhof EM; van Gils CH; Groenwold RHH; Elias SG; van den Bongard DHJG; Peeters PHM; Verkooijen HM; May AM
    Breast Cancer Res Treat; 2021 Nov; 190(1):89-101. PubMed ID: 34427806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.